Education Proves More Effective Than Reminders At Improving Hypertension Patient Medication Adherence

Published Jul 9, 2013
London, ON, Canada - Sub-optimal medication adherence with hypertension medication is associated with uncontrolled blood pressure and an increasing economic burden. Researchers, clinicians, and policy makers continue to explore new ways of promoting antihypertensive medication adherence, however, there is little consensus on the best way to do this. The ISPOR Medication Adherence & Persistence Special Interest Group conducted a comprehensive systematic review of all evidence published on adherence-enhancing interventions in hypertension. The aim was to help stakeholders determine which strategies promote optimal adherence. The results of the review indicate that interventions aimed at increasing patients’ knowledge of medications carry the greatest potential in improving adherence to antihypertensive medication. Education-based strategies prove to be more effective than a variety of other methods including reminders, packaging, and support groups. Dr. Femida Gwadry-Sridhar, lead author on the study, says, “With increasing emphasis on affordable health care and comparative effectiveness, it is important that we address the challenge of non-adherence and recognize that it poses a significant threat to productivity in society. Novel and engaging ways of promoting sustained adherence behaviour that embrace technologies like the internet and mobile devices present exciting opportunities in health research. Our review provides an evidence-based approach to the future design and implementation of such studies.” The full study, “Impact of Interventions on Medication Adherence and Blood Pressure Control in Patients with Essential Hypertension: A Systematic Review by the ISPOR Medication Adherence and Persistence Special Interest Group,” is published in Value in Health.

Value in Health (ISSN 1098-3015) publishes papers, concepts, and ideas that advance the field of pharmacoeconomics and outcomes research as well as policy papers to help health care leaders make evidence-based decisions. The journal is published bi-monthly and has over 8,000 subscribers (clinicians, decision makers, and researchers worldwide).

International Society for Pharmacoeconomics and Outcomes Research (ISPOR) is a nonprofit, international, educational and scientific organization that strives to increase the efficiency, effectiveness, and fairness of health care resource use to improve health.

For more information: www.ispor.org

Related Stories

Rethinking Value Assessment for Orphan Drugs

Dec 18, 2024

Value in Health, the official journal of ISPOR—The Professional Society for Health Economics and Outcomes Research, announced the publication of a special themed section of research papers that document challenges in rare disease evidence and economic evaluation and policy as well as ways in which the environment is evolving to address them.

ISPOR Releases Emerging Good Practices Guidance on Quantifying Specialized Knowledge in Healthcare

Nov 6, 2024

ISPOR announced the publication of an ISPOR Good Practices Report that identifies existing structured expert elicitation protocols that can support healthcare decision making and provides important insights on how to choose which protocols may be the most appropriate for different scenarios, such as time-constrained decisions, early-stage technology assessments, and public health policies.

Measuring What Matters: Broadening the Scope of Health Economics Evaluation to Incorporate Well-Being

Jul 9, 2024

ISPOR announced the publication of a special themed section of research papers in Value in Health that offer insights into facets of economic evaluation aimed to incorporate well-being into decision making.
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×